Bio-Thera Solutions has achieved a world first after receiving approval for its BAT1806 biosimilar rival to Actemra/RoActemra from China’s National Medical Products Administration.
“BAT1806 is the first tocilizumab biosimilar approved by the NMPA or any other regulatory agency around the world and has...






